Literature DB >> 16222889

Endothelial dysfunction, distensibility and intima-media thickness and aetiology of stroke.

I Chlumský1, J Charvát.   

Abstract

This study measured carotid artery distensibility, intima-media thickness (IMT) and flow-mediated dilatation (FMD) in patients with ischaemic stroke and evaluated if there was a relationship between these measurements and the presence of atrial fibrillation. Distensibility and IMT were measured in 89 patients with ischaemic stroke using ultrasonography; 44 patients had atrial fibrillation. Distensibility was determined using the Reneman equation. FMD was measured in a second group of 52 patients with ischaemic stroke; 20 patients had atrial fibrillation. Patients with atrial fibrillation had lower IMT values compared with patients without atrial fibrillation (0.67 versus 0.79 mm, respectively). Distensibility increased in patients with atrial fibrillation compared with patients without atrial fibrillation (0.19 versus 0.10 mm/100 mmHg, respectively). Patients with atrial fibrillation had significantly better FMD results than patients without atrial fibrillation (5.7% versus 3.2%, respectively). Measuring distensibility, IMT and FMD might be helpful in differentiating between stroke of embolic and thrombotic aetiology.

Entities:  

Mesh:

Year:  2005        PMID: 16222889     DOI: 10.1177/147323000503300511

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  2 in total

1.  Endothelial dysfunction is an independent risk factor for stroke patients irrespective of the presence of patent foramen ovale.

Authors:  M Sunbul; B Ozben; E Durmus; A Kepez; A Pehlivan; I Midi; B Mutlu
Journal:  Herz       Date:  2013-02-16       Impact factor: 1.443

2.  Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study.

Authors:  Christopher D Beer; Kathleen Potter; David Blacker; Leonard Arnolda; Graeme J Hankey; Ian B Puddey
Journal:  Cardiovasc Ultrasound       Date:  2010-10-19       Impact factor: 2.062

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.